Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® coronavirus specialty page provides clinical news and articles, links to condition-specific resources, and videos on the coronavirus.


Systematic Review Highlights Hydroxychloroquine Ambiguities
Investigators sought to summarize evidence about the benefits and harms of hydroxychloroquine and chloroquine as treatments or prophylaxis of COVID-19.
CIDRAP Advocates for COVID-19
A new report outlines the proven steps needed to implement a national strategy for SARS-CoV-2 screening.
ACE Inhibitors, ARBs Do Not Worsen COVID-19 Risk
Early links between heart disease and diabetes and coronavirus severity caused some to fear that the 2 classes of medication might worsen outcomes during the pandemic. A systematic review finds little evidence to back those fears.
FDA Grants Emergency Use to Quest Diagnostics COVID-19 Self-Collection Kit
Collected specimens can be tested with the Quest Diagnostics SARS-CoV-2 RT-PCR test to have received EUA from the FDA earlier in March.
Why Comparing Flu and COVID-19 Severity Is Not Equivalent
Experts argue that though public officials may liken coronavirus to "just another flu," the true numbers show a stark difference.
Less Nasal ACE2 May Explain Fewer COVID-19 Cases in Children
Less ACE2 in nasal epithelium in children could present barrier to SARS-CoV-2 and explain the lower observed rate of pediatric infections.
Remdesivir Trial Inconclusive on Treatment Duration for COVID-19
An assessment of severe coronavirus patients administered either five-day or 10-day remdesivir treatment shows benefit is fairly similar, regardless of duration.
How Cancer Type Can Affect COVID-19 Risk
A new paper analyzed cancer types to determine which types of cancer put a patient at highest risk of contracting coronavirus.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?